Hard cancers have significantly higher GLUT1 expression, an indicator of hypoxia, and levels of prognostic biomarkers such as ER negativity, PR negativity, Ki67 positivity, high grade, and HER2-overexpressing and triple-negative molecular subtypes. The gene discussed is ESR1; the disease is cancer.